Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 9 May 24 424B3 Prospectus supplement
- 30 Apr 24 EFFECT Notice of effectiveness
- 29 Apr 24 424B3 Prospectus supplement
-
19 Apr 24 S-1 IPO registration
QTTB similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement on Form S-1 of our report dated March 12, 2024, relating to the financial statements of Homology Medicines, Inc. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Deloitte & Touche LLP |
Boston, Massachusetts |
April 19, 2024